Analyst Reco. Generation Bio Co.

Equities

GBIO

US37148K1007

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-09 pm EDT			5-day change	1st Jan Change
3.26 ^USD	+5.16%		+4.82%	+97.58%

12:59pm	Generation Bio Co. Announces the Presentation of Preclinical Data on iqDNA and ctLNP Platforms At the ASGCT 27th Annual Meeting	CI
Apr. 12	Transcript : Generation Bio Co. - Special Call

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Needham Cuts Price Target on Generation Bio to $10 From $14, Maintains Buy Rating	Mar. 07	MT
Wedbush Adjusts Generation Bio Price Target to $5 From $9, Maintains Outperform Rating	Nov. 29	MT
Wedbush Lowers Generation Bio's Price Target to $9 From $11, Maintains Outperform Rating	Nov. 10	MT
JMP Securities Downgrades Generation Bio to Market Perform From Market Outperform	23-10-23	MT
TD Cowen Downgrades Generation Bio to Market Perform From Outperform	23-10-19	MT
JPMorgan Chase Adjusts Price Target on Generation Bio to $9 From $8, Maintains Neutral Rating	23-08-16	MT
Wedbush Cuts Generation Bio's Price Target to $11 From $15, Maintains Outperform Rating	23-03-23	MT
Needham Adjusts Price Target on Generation Bio to $14 From $23, Maintains Buy Rating	23-02-24	MT
Wedbush Lowers Generation Bio's PT to $15 From $24, Pushes Out Launch Timings for Each Indication, Adjusts Capital Raise Assumptions; Keeps Outperform Rating	23-02-24	MT
JMP Securities Adjusts Price Target on Generation Bio to $7 From $11, Maintains Market Outperform Rating	23-01-19	MT
Canaccord Genuity Starts Generation Bio at Buy With $9 Price Target	22-11-08	MT
JMP Securities Adjusts Generation Bio's Price Target to $11 from $10, Keeps Market Outperform Rating	22-08-08	MT
Needham Adjusts Generation Bio's Price Target to $23 from $27, Keeps Buy Rating	22-08-05	MT
Wedbush Adjusts Price Target for Generation Bio to $24 From $23, Maintains Outperform Rating	22-06-21	MT
Wedbush Lowers Generation Bio's Price Target to $23 From $25, Citing Cost of Capital, Keeps Outperform Rating	22-05-06	MT
Wedbush Cuts Generation Bio's Price Target to $25 From $31, Citing Pipeline Timeline Adjustments, Keeps Outperform Rating	22-02-25	MT
Jefferies Adjusts Price Target for Generation Bio to $29 From $38, Maintains Buy Rating	21-12-15	MT
JMP Securities Adjusts Price Target on Generation Bio to $10 From $40, Maintains Market Outperform Rating	21-12-15	MT
Needham Adjusts Price Target on Generation Bio to $27 From $50, Maintains Buy Rating	21-12-15	MT
JPMorgan Downgrades Generation Bio to Neutral From Overweight, Sets $17 Price Target	21-12-14	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. Generation Bio Co.

Equities

GBIO

US37148K1007

Analyst Reco.

Filters